Integral Embodied Leadership Cohort for the Healthcare C-Suite

Last updated: May 2026

A 9-month cohort developing nervous-system regulation, embodied decision-making, and team-level cohesion as measurable leadership capabilities — for the health plan, PBM, specialty pharmacy, and managed care executives carrying the weight of disruption that no standard leadership program was built for.

Delivered by Thomas G. Goddard, JD, PhD, CCEP, founding member of the Integral Institute of Medicine, with 40+ years across U.S. healthcare regulation, policy, and organizational practice.

What This Cohort Is

The Integral Embodied Leadership Cohort for the Healthcare C-Suite is a 9-month cohort program for 8–12 senior healthcare executives that develops whole-person leadership capacity — autonomic regulation, relational coherence, cognitive clarity under load, and reconnection to the moral source of healthcare leadership. Delivered by Thomas G. Goddard, JD, PhD, CCEP. It is for senior executives who are willing to have their own leadership examined, not only their strategies and teams. It is built on the premise that in 2026, the binding constraint on C-suite performance in health plans, PBMs, specialty pharmacies, managed behavioral healthcare organizations, and MCOs is not the absence of good strategy. It is the gap between the executive's physiological state and the quality of judgment that state produces; between the relational field in the room and the decisions that field makes possible; between the executive's connection to the moral source of their work and their capacity to lead through the disruption that work now requires.

The cohort addresses all three gaps in a structured, evidence-grounded, nine-month arc. It uses the body as the primary instrument — not as a metaphor, but as the empirical carrier of executive decision quality that the somatic-marker and polyvagal research has documented for three decades.

That premise runs against the standard healthcare leadership model, which treats the C-suite as the layer that formulates strategy and manages execution. The integral framing does not contradict that model; it names what is missing from it. A CEO, CMO, CFO, and COO running a health plan or specialty pharmacy through simultaneous AI deployment, prior-authorization rule churn, payer-counterparty conflict, and possible cybersecurity exposure are doing cognitively demanding work in a physiologically demanding context. Their individual leadership development — if it exists — almost never addresses the autonomic layer where most of their highest-stakes decisions are actually being shaped. The cohort addresses that layer, in the company of peers who are carrying the same load from different seats.

What Participants Develop

  • Nervous-system regulation under organizational load — the capacity to recognize and shift autonomic state in real time, before it determines a decision. Not resilience in the generic sense; calibrated regulation of the physiological substrate that either supports or degrades executive judgment in high-stakes moments.
  • Embodied decision-making — the ability to read somatic markers as real-time data about risk, relational fit, and organizational readiness, and to integrate that data with cognitive analysis rather than suppress it. The capacity to know what you actually know before you announce what you think.
  • Team-level relational coherence — the ability to read and shift the relational field of a leadership team as a collective instrument, not only as a collection of individuals. The four-quadrant capacity of the team as a whole determines what the team can and cannot hear, decide, and hold.
  • Reconnection to moral source and vocation — the re-anchoring of meaning and purpose in a leadership role that has been eroded by the conditions inside U.S. healthcare in 2026. Not motivation work; the deeper repair of the relationship between the executive and what brought them to this work. This dimension addresses moral injury at the leadership level — the specific damage done when an executive is structurally implicated in institutional decisions they find inadequate.

What This Cohort Does Not Claim

The cohort does not diagnose or treat any clinical or psychiatric condition in any participant. It is not psychotherapy, clinical psychology, pastoral counseling, or chaplaincy. It is an organizational-consulting and executive-development program.

It does not promise specific patient-outcome or financial-performance results; the causal chain from leadership development to clinical outcomes is empirically real but too long to commit to in scope. It does not substitute for the participant's existing Employee Assistance Program or therapeutic relationship.

The Science Behind It

The cohort is grounded in four converging research lineages integrated into one leadership-development methodology calibrated to healthcare in 2026.

The body layer rests on Stephen Porges's polyvagal theory of autonomic regulation applied at the executive level: the autonomic state a leader is in is not independent of the quality of the judgment they produce from it (Porges, Psychophysiology, 1995; The Polyvagal Theory, 2011). Antonio Damasio's somatic marker hypothesis establishes that interoceptive signals function as real-time data in executive decision-making — the executive who cannot read their own somatic state is making decisions with a primary data source switched off (Damasio, Descartes' Error, 1994; Bechara & Damasio, Games and Economic Behavior, 2005). The cohort builds the specific regulation practices that move autonomic state before high-stakes decisions, and the interoceptive literacy that makes somatic data available to the cognitive layer rather than bypassed by it.

The heart layer addresses two dimensions the wellness market routinely collapses into one. First, the emotional toll of healthcare executive work in 2026 — the sustained sorrow of leading an organization structurally implicated in care decisions one finds inadequate, the accumulation of organizational grief, the weight of the gap between the institution's stated mission and what the institution actually authorizes. Second, the relational coherence of the leadership team as a collective: the between-people field where the emotional load either degrades or is held, and where psychological safety either exists or does not. Anchors: Maslach Burnout Inventory (1981); secondary traumatic stress literature (Figley, 1995; Stamm, 2005); Edmondson on psychological safety and clinical-team learning (Administrative Science Quarterly, 1999); Schwartz Center Rounds evidence base (Lown & Manning, Academic Medicine, 2010).

The mind layer draws on the I/O psychology literature on senior team effectiveness and the organizational determinants of leadership performance under load. Hackman's research on top management team conditions establishes that the leadership team must be treated as the unit of intervention, not only the individuals who compose it (Leading Teams, 2002). Trockel et al.'s finding that organizational factors account for approximately 70% of physician burnout variance applies equally to the leadership layer: the executive's organizational context shapes their capacity at least as much as their individual practice does (Trockel et al., JAMA Internal Medicine, 2018).

The meaning and purpose layer is grounded in the PNHP 2026 Moral Injury in Medicine Report and the medical-vocation literature it builds on (Dean & Talbot, 2018). The report distinguishes moral injury from burnout and argues that framing executive distress as burnout has produced a generation of ineffective interventions. For a long-tenured C-suite executive in 2026, the question is not resilience; it is whether their connection to why they do this work has survived what the work has become. The cohort addresses that question directly, using Schwartz Rounds methodology adapted to senior leadership formats and the moral-injury construct as the clinical anchor for meaning-work within healthcare scope.

Who Belongs in This Cohort

The cohort is calibrated to senior executives whose work sits at the intersection of regulated healthcare operations and the full organizational load of disruption: PE consolidation, M&A friction, regulatory churn at the payer and PBM layer, and the vocation crisis among long-tenured executives whose institutions have changed faster than their leadership development has. The primary buyer is the CEO; secondary buyers include the CHRO and the Board.

The C-suite environment is the operating pressure. 82% of US physicians are now employed by hospitals, PE platforms, insurers, or other corporate entities (Avalere/PAI). Across industries, 70–90% of M&A deals fail to deliver projected value; only 14% of healthcare M&A reaches successful integration (Bain via VALUWIT). Independent rural hospitals projected to lose $465 million in patient revenue in 2026 due to federal Medicaid cuts — average $630,665 per hospital, 56% of yearly net income (Families USA). Trockel et al. (JAMA Internal Medicine, 2018) found organizational factors account for approximately 70% of physician burnout variance, establishing that the executive lever is structural. The cohort develops the regulated capacity that allows the executive to make structural decisions from regulated physiology rather than chronic activation.

  • Health plans and managed care organizations — CEOs, CMOs, COOs, CCOs, and Chief Clinical Officers carrying the weight of CMS-0057-F implementation, prior-authorization rule churn, Medicare Advantage compression, and the AI-governance questions their UM staff are living before the executive layer has named them.
  • Pharmacy benefit managers — C-suite and clinical leadership teams operating under simultaneous interoperability pressure, formulary-design scrutiny, and step-therapy enforcement — functions where the moral load on clinical pharmacists flows upward to the leadership layer whether or not the cabinet has acknowledged it.
  • Specialty pharmacies — CEOs, Chief Clinical Officers, and VPs of Patient Access whose organizations are absorbing the downstream effects of payer-mix complexity, copay-accumulator unwinding, and prior-authorization cascades at the clinical staff level, and whose own leadership cohesion is under pressure from growth-by-acquisition.
  • Managed behavioral healthcare organizations — executive teams operating in the sector with the most documented workforce-supply collapse, where the leadership layer is absorbing attrition, utilization-review scrutiny, and mental health parity compliance simultaneously.
  • Hospital systems and health systems — C-suite cabinets in the 18–36 month window following a major merger, acquisition, or sentinel event, where integration-fatigue and moral injury at the executive layer are the leading indicators of trajectory.
  • PE-portfolio platform companies in healthcare — platform CEOs and operating-partner-sponsored executive teams in the 0–36 month post-close window, where the founding-clinician meaning crisis and integration-fatigue pattern in acquired leadership teams are measurable and addressable before they become attrition events.
  • FQHCs, MCOs, and other Medicaid-serving organizations — executive leadership facing the cadence of state-mandate change, Medicaid managed care rate pressure, and the mission-sustainability questions that surface when the gap between mission and margin widens.

The 9-Month Program Structure

The program runs across three arcs. The first three months build the individual somatic and relational foundation without which the deeper work cannot hold. The middle three months extend that foundation to the participant's own leadership team and into the specific organizational conditions each executive carries. The final three months work with meaning, vocation, and the long-term sustainability question — who the executive is becoming as a leader, and whether the institution they are building is one they can inhabit.

Monthly Cadence

Each month includes one two-day group intensive with the full cohort (in-person where geography permits, hybrid otherwise) and one 60-minute individual coaching session with the principal. Intensives are not lecture formats; they are structured working sessions combining somatic practice, group reflection, peer-case consultation, and direct application to the organizational challenges participants bring. The peer-case consultation format is adapted from Schwartz Rounds methodology for senior leadership contexts — the group learns from each other's live organizational situations across the year.

The Cohort as Peer-Learning Community

Executives from different organizations learning from each other across a year is a structural feature of the cohort, not a side benefit. The peer-learning dynamic produces something individual coaching cannot: a cross-organizational view of what the disruption actually looks like from inside competing institutions, in real time. Participants from a health plan, a PBM, and a specialty pharmacy bring different seats at the same table. The relational field that develops across the year is frequently cited as the most durable value of the program.

The Mid-Program Team Intervention

At program midpoint, each participant who elects the intervention receives a one or two-day working session with their own leadership team — the people who report to or alongside them in their organization, not the cohort. The session is facilitated by the principal and focuses on the four-quadrant state of the participant's team as a collective: the team's autonomic field, its relational coherence, its shared cognitive capacity under load, and the meaning-and-purpose signal the team carries or has lost. The participant enters this session with six months of somatic and relational capacity from the cohort; the session is where that capacity meets the specific team they lead.

What Changes Across the Program Arc

The program is not nine identical months. The first three months work primarily at the individual somatic and interoceptive level — building the basic regulation vocabulary, the body-reading practices, and the capacity to stay present in the specific organizational conditions each participant carries. Participants frequently report that months one through three feel unfamiliar in a way that is more disorienting than difficult; they are learning a layer of data about themselves that no prior leadership development has made available.

Months four through six shift the work to the collective level. The group deepens as a peer community, the individual practices begin to apply in real organizational moments rather than only in the intensive context, and the mid-program team intervention brings the work into direct contact with the participant's own leadership team. This is frequently the period where the personal developmental work and the organizational leadership work become visibly connected.

The final three months address the meaning and vocation question directly — the long-term sustainability of the executive's relationship to their work and to the institution they are building. For long-tenured executives, this is often the most consequential work of the year. It is also frequently the work that standard leadership development never reaches because it requires the somatic and relational foundation the first six months have built.

What Participants Receive

  • Pre-cohort individual nervous-system assessment — a structured pre-program assessment of each participant's autonomic baseline, regulation patterns, and leadership-load profile. Conducted by the principal; findings are confidential to the participant and used to calibrate their individual arc within the cohort year.
  • Nine monthly two-day group intensives — 18 days across the year of structured somatic, relational, cognitive, and meaning-and-purpose work with the full cohort, in-person or hybrid per geography.
  • Nine monthly individual coaching sessions — 60 minutes per month with the principal, calibrated to each participant's specific organizational context and developmental arc.
  • Mid-program team intervention — at program midpoint, an elected one or two-day working session with the participant's own leadership team. Scoped as a four-quadrant diagnostic and facilitated intervention with the team the participant leads.
  • 90-day post-cohort follow-up engagement — three monthly 60-minute individual check-ins after the program ends, supporting integration of cohort-year gains back into full organizational pace and addressing what the participant is now ready to do institutionally.

Why This Differs

From Executive Coaching

Individual executive coaching addresses the individual. It does not address the collective — the team as a single instrument, the relational field as a shared resource, the peer-learning that happens when executives from different organizations examine the same disruption from different institutional seats. The cohort produces individual development and collective development simultaneously; coaching alone produces only the first. The cohort also builds the somatic-regulation foundation that individual coaching rarely reaches because it rarely has the time or the group context to hold it.

From a Standard Leadership Cohort Program

Standard leadership cohort programs — offered through executive education providers, health system academies, and leadership consulting firms — address the mind layer. They build cognitive frameworks, strategic models, and leadership competency vocabularies. They do not address autonomic state, do not surface the emotional toll and relational coherence that determine whether a cognitive framework can actually be applied under load, and do not address the meaning-and-purpose dimension that distinguishes a long-tenured executive's vocation crisis from a skills gap. The integral cohort integrates body, heart, mind, and meaning-and-purpose work across the year. That integration is the structural difference.

From an Executive Education Program

Executive education — at business schools and professional schools — trains cognitive knowledge at the class-cohort scale. It does not provide individual coaching, does not address the somatic layer of decision-making, does not include a team intervention inside the participant's own organization, and does not address the meaning and purpose work that long-tenured executives in a vocation crisis need. It is a different product for a different purpose.

From a Wellness Vendor or Wellbeing Platform

BetterUp, Lyra, Spring Health, and similar platforms address individual self-report through app-mediated content and coaching. The evidence base for individual wellbeing apps in healthcare leadership development is thin. None of these vendors operates at the team or organizational level, none addresses the somatic-regulation foundation of executive decision quality, and none is built by a principal with regulatory fluency in the segments where the leadership load is highest — health plans, PBMs, specialty pharmacies, and MBHOs. The wellness vendor's frame treats the executive's distress as an individual problem to be managed. The integral cohort treats it as an organizational and vocational condition to be addressed at the level where it actually originates.

Why IHS for This Cohort

The Integral Embodied Leadership Cohort for the Healthcare C-Suite is principal-delivered. It is calibrated to the specific organizational conditions of U.S. healthcare in 2026 by a consultant whose credential combination no executive-education provider, leadership coaching firm, or wellness vendor can assemble.

About the Principal

Thomas G. Goddard, JD, PhD, CCEP — CEO of Integral Healthcare Solutions; Founding Member of the Integral Institute of Medicine.

Forty-plus years across U.S. healthcare regulation, policy, and organizational practice: Special Assistant to a U.S. governor on Medicaid policy; Counsel for Government and Media Relations at the National Association of Insurance Commissioners; VP and General Counsel of NYLCare Health Plans of the Mid-Atlantic (500,000 members); COO and General Counsel of URAC; Senior Consultant at Booz Allen Hamilton; twenty-four years as CEO of Integral Healthcare Solutions. Faculty appointments at George Mason University School of Management and Seton Hall Law School's Healthcare Compliance Certification Program.

PhD in Industrial-Organizational Psychology (George Mason University) — the measurement and validation discipline behind every assessment instrument used in the cohort. Juris Doctor (University of Arizona). Certified Core Energetics Practitioner (Institute of Core Energetics) — one of the few CCEP-credentialed consultants in U.S. healthcare. Expert witness in Wit v. United Behavioral Health and seven other federal and state cases. Twenty-five years applying an integral framework to healthcare in peer-reviewed and conference work, including the AQAL: Journal of Integral Theory and Practice, Healthcare Financial Management, the Journal of Alternative and Complementary Medicine, and Explore: The Journal of Science and Healing.

Frequently Asked Questions

How large is the cohort?

Cohorts are capped at 8-12 senior executives. That ceiling is deliberate: the group format depends on a relational field of sufficient density and sufficient trust to do the work the cohort is designed to do. Below 8, the peer-learning dynamic is thin. Above 12, the principal cannot maintain the individual thread required alongside the group work.

Is there a selection or application process?

Yes. Each participant is interviewed by the principal before admission. The interview is a fit screen, not a credential screen. The program works when every participant is genuinely willing to have their leadership examined — not only their strategy or their team — and when the cohort mix includes enough functional diversity to produce peer-learning across the year. Applications are reviewed on a rolling basis as cohort openings become available; early inquiry is recommended given the 8-12 participant ceiling.

How much in-person time does the program require?

Nine monthly two-day intensives — 18 days across the year. For cohorts where geography permits, intensives are in-person; for distributed cohorts, they run in a structured hybrid format. Monthly individual coaching runs by video.

Participants come from competing organizations. How is confidentiality handled?

Cohort participants sign a mutual confidentiality agreement before the first intensive. The principal does not share any participant's individual content — including one-on-one coaching content — with any other participant or with the sponsoring organization.

What does a participant bring back to their organization?

Three things: a measurably more regulated nervous system with practices that hold under organizational load, a stronger relational field with their own leadership team, and a peer network of senior healthcare executives who have done the same work. The peer network is frequently cited as the most durable value of the cohort year.

What is the scope of the mid-program team intervention?

A one or two-day facilitated working session with the participant's own leadership team — not the cohort. Focused on the team's relational field, psychological safety, and four-quadrant collective state. It is a structured diagnostic and intervention, not a retreat or team-building event. It is offered as an elected component; participants who are not ready to bring this work to their teams at program midpoint may defer or decline it.

What happens during the 90-day post-cohort follow-up?

Three monthly 60-minute individual check-ins supporting integration of cohort-year gains back into full organizational pace — covering practice stability under pressure, relational field maintenance, and what the participant is now ready to do institutionally that they were not ready to do before the cohort year.

What is the evidence base?

The cohort methodology is grounded in Porges's polyvagal theory applied to leadership autonomic regulation and decision-making quality (Porges, Psychophysiology, 1995; The Polyvagal Theory, 2011); Damasio's somatic marker hypothesis and its implications for executive judgment under uncertainty (Damasio, Descartes' Error, 1994; Bechara & Damasio, Games and Economic Behavior, 2005); Hackman's conditions-for-senior-team-effectiveness research establishing that the top management team is the unit of intervention (Leading Teams, 2002); Trockel et al.'s finding that organizational factors account for approximately 70% of physician burnout variance (Trockel et al., JAMA Internal Medicine, 2018); and the Schwartz Center Rounds peer-reviewed evidence base adapted to a senior leadership context (Lown & Manning, Academic Medicine, 2010). The moral injury dimension draws on the PNHP 2026 Moral Injury in Medicine Report (Dean & Talbot, 2018) and Frankl's logotherapy tradition as synthesized through contemporary medical-vocation literature.

How is the program priced?

The program is scoped per cohort based on cohort size, geography, and whether the mid-program team intervention is elected. The proposal covers the full nine-month program, including all group intensives, individual coaching, pre-cohort assessments, and the 90-day post-cohort follow-up. Contact us for a tailored proposal. IHS does not publish a fee schedule because each engagement is principal-delivered at the scope the leadership team commissions — there is no productized rate card to publish. The reference point is the cost of executive judgment made from compromised physiology — in a sector where 14% of healthcare M&A reaches successful integration (Bain via VALUWIT) and rural hospital financial volatility is at a multi-year high (Families USA). Contact us for a tailored proposal.

Related Resources

Ready to Get Started?

Schedule a no-obligation consultation with IHS. We will discuss whether the Integral Embodied Leadership Cohort is the right fit for you or your organization, and whether the next cohort opening meets your timeline.

Cohort openings are limited. Engagements are scoped per cohort — contact for a proposal.

Schedule a Free Discovery Session